1. Home
  2. VFC vs TMDX Comparison

VFC vs TMDX Comparison

Compare VFC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VFC
  • TMDX
  • Stock Information
  • Founded
  • VFC 1899
  • TMDX 1998
  • Country
  • VFC United States
  • TMDX United States
  • Employees
  • VFC N/A
  • TMDX N/A
  • Industry
  • VFC Apparel
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • VFC Consumer Discretionary
  • TMDX Health Care
  • Exchange
  • VFC Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • VFC 4.1B
  • TMDX 4.8B
  • IPO Year
  • VFC N/A
  • TMDX 2019
  • Fundamental
  • Price
  • VFC $12.58
  • TMDX $129.19
  • Analyst Decision
  • VFC Buy
  • TMDX Buy
  • Analyst Count
  • VFC 18
  • TMDX 10
  • Target Price
  • VFC $16.28
  • TMDX $127.33
  • AVG Volume (30 Days)
  • VFC 7.1M
  • TMDX 808.7K
  • Earning Date
  • VFC 08-05-2025
  • TMDX 07-30-2025
  • Dividend Yield
  • VFC 2.86%
  • TMDX N/A
  • EPS Growth
  • VFC N/A
  • TMDX N/A
  • EPS
  • VFC N/A
  • TMDX 1.41
  • Revenue
  • VFC $9,504,691,000.00
  • TMDX $488,227,000.00
  • Revenue This Year
  • VFC $0.92
  • TMDX $34.07
  • Revenue Next Year
  • VFC $3.39
  • TMDX $20.76
  • P/E Ratio
  • VFC $70.62
  • TMDX $91.70
  • Revenue Growth
  • VFC N/A
  • TMDX 64.43
  • 52 Week Low
  • VFC $9.41
  • TMDX $55.00
  • 52 Week High
  • VFC $29.02
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • VFC 53.14
  • TMDX 51.09
  • Support Level
  • VFC $11.42
  • TMDX $120.36
  • Resistance Level
  • VFC $12.82
  • TMDX $136.63
  • Average True Range (ATR)
  • VFC 0.48
  • TMDX 6.03
  • MACD
  • VFC 0.11
  • TMDX -1.68
  • Stochastic Oscillator
  • VFC 84.66
  • TMDX 35.12

About VFC V.F. Corporation

VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 11 brands includes Vans, The North Face, Timberland, Altra, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: